Case number 2018-1710
Purdue Pharma L.P. v. Iancu > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | PURDUE PHARMA L.P. v. IANCU [OPINION - NONPRECEDENTIAL] a [nonprecedential] (0) |
| Dec 6, 2019 | 84 | Notice from the Supreme Court of the United States: The application for an extension of time within which to file a petition for a writ of certiorari in the above-entitled case has been presented to The Chief Justice, who on November 25, 2019, extended the time to and including February 6, 2020. [654457] [JAB] [Entered: 12/06/2019 07:47 AM] (0) |
| Sep 16, 2019 | 83 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [635626] [18-1710, 18-1711] [JAB] [Entered: 09/16/2019 09:55 AM] (0) |
| Sep 9, 2019 | 82 | ORDER filed denying [73] petition for panel rehearing filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc.; denying [73] petition for en banc rehearing filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [633897] [JAB] [Entered: 09/09/2019 09:09 AM] (0) |
| Aug 13, 2019 | 80 | Notice to counsel for Intervenor Iancu: The record of this case indicates that the paper copies of the response to rehearing petition (see Fed. Cir. R. 35(c)(4)) have not been filed. The required paper copies should be received by the court on or before 08/15/2019. Service as of this date by the Clerk of Court. [627792] [JAB] [Entered: 08/13/2019 08:06 AM] (0) |
| Aug 13, 2019 | 81 | 18 paper copies of the response [79] received from Intervenor Iancu. [627933] [JAB] [Entered: 08/13/2019 02:25 PM] (0) |
| Aug 7, 2019 | 78 | Notice of Correction to Doc No. [77] for Intervenor Iancu. Service: 08/07/2019 by email. [626829] [18-1710] [Mary Kelly] [Entered: 08/07/2019 05:49 PM] (0) |
| Aug 7, 2019 | 79 | RESPONSE of Intervenor Iancu to the petition for panel rehearing [73] filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P., petition for en banc rehearing [73] filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 08/07/2019 by email. [626830] [18-1710] [Mary Kelly] [Entered: 08/07/2019 05:52 PM] (0) |
| Aug 6, 2019 | 76 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor Iancu. Service: 08/06/2019 by email. [626135] [18-1710] [Farheena Rasheed] [Entered: 08/06/2019 08:20 AM] (0) |
| Aug 6, 2019 | 77 | MODIFIED ENTRY: RESPONSE of Intervenor Iancu to the petition for panel rehearing [73] filed by Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc., petition for en banc rehearing [73] filed by Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc. Service: 08/06/2019 by email. [626524]--[Edited 08/07/2019 by JCA - Reason: to correct filing event] [Mary Kelly] [Entered: 08/06/2019 08:05 PM] (0) |
| Jul 23, 2019 | 75 | The court invites a response from Intervenor Iancu to the petition for panel rehearing, petition for en banc rehearing filed by Appellants in 18-1710. The response is due on or before 08/06/2019. [622795] [JAB] [Entered: 07/23/2019 10:16 AM] (0) |
| Jul 19, 2019 | 74 | 18 paper copies of the petition for panel rehearing [73], petition for en banc rehearing [73] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [622752] [JAB] [Entered: 07/23/2019 08:58 AM] (0) |
| Jul 18, 2019 | 73 | Petition for panel rehearing, for en banc rehearing filed by Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Service: 07/18/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 07/22/2019 [622063] [18-1710] [Robert Stander] [Entered: 07/18/2019 04:38 PM] (45) |
| May 28, 2019 | 72 | ORDER filed granting motion to extend time to file petition for rehearing [71] filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [609776] [MJL] [Entered: 05/28/2019 12:00 PM] (2) |
| May 23, 2019 | 71 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 07/18/2019 [Consent: unopposed]. Service: 05/23/2019 by email. [609395] [18-1710] [Robert Stander] [Entered: 05/23/2019 03:18 PM] (9) |
| Apr 17, 2019 | 70 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Each side bears its own costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [600888] [18-1710, 18-1711] [PBC] [Entered: 04/17/2019 09:22 AM] (2) |
| Apr 17, 2019 | 69 | OPINION filed for the court by Dyk, Circuit Judge; Mayer, Circuit Judge and Bryson, Circuit Judge. Nonprecedential Opinion. [600887] [18-1710, 18-1711] [PBC] [Entered: 04/17/2019 09:20 AM] (17) |
| Apr 2, 2019 | 68 | Submitted after ORAL ARGUMENT by Jennifer Loraine Swize for Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc. and Mary L. Kelly for Iancu. Panel: Judge: Dyk , Judge: Mayer , Judge: Bryson. [597170] [JAB] [Entered: 04/02/2019 12:49 PM] (0) |
| Mar 15, 2019 | 67 | Response to notice of oral argument from the Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [593204] [18-1710] [Robert Stander] [Entered: 03/15/2019 01:16 PM] (3) |
| Mar 14, 2019 | 66 | Response to notice of oral argument from the Intervenor Iancu. [592814] [18-1710] [Mary Kelly] [Entered: 03/14/2019 11:50 AM] (3) |
| Feb 22, 2019 | 65 | NOTICE OF ORAL ARGUMENT. Panel: 1904I. Case scheduled Apr 02, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 03/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [588063] [JAB] [Entered: 02/22/2019 03:02 PM] (2) |
| Jan 16, 2019 | 64 | Notice of Appointment of New Solicitor from Patent and Trademark Office. Service: 01/22/2019 by clerk. [579639] [SJ] [Entered: 01/22/2019 11:18 AM] (1) |
| Dec 10, 2018 | 63 | Notice from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. regarding conflicts with oral argument. Service: 12/10/2018 by email. [570668] [18-1710] [Robert Stander] [Entered: 12/10/2018 07:07 PM] (3) |
| Dec 6, 2018 | 62 | 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - II) [56] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [570297] [CJF] [Entered: 12/07/2018 03:49 PM] (0) |
| Dec 6, 2018 | 61 | 6 paper copies of the Reply Brief [55] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [569987] [CJF] [Entered: 12/06/2018 03:52 PM] (0) |
| Dec 6, 2018 | 60 | Notice from Intervenor Iancu regarding conflicts with oral argument. Service: 12/06/2018 by email. [569838] [18-1710] [Mary Kelly] [Entered: 12/06/2018 11:08 AM] (2) |
| Dec 3, 2018 | 59 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [569370] [SJ] [Entered: 12/03/2018 03:55 PM] (0) |
| Dec 3, 2018 | 58 | Notice to Advise of Scheduling Conflicts. Please advise of any scheduling conflicts during the upcoming court session months listed in the attached Notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [569367] [SJ] [Entered: 12/03/2018 03:53 PM] (1) |
| Nov 28, 2018 | 56 | CONFIDENTIAL JOINT APPENDIX FILED (2 vols.) for P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. Number of Pages: 830. Service: 11/28/2018 by email. [568348]--[compliance review complete 12/03/2018 by SMJ] [Robert Stander] [Entered: 11/28/2018 06:23 PM] (0) |
| Nov 28, 2018 | 57 | APPENDIX FILED (2 vols.) for P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. Number of Pages: 707. Service: 11/28/2018 by email. [568349] --[compliance review complete 12/03/2018 by SMJ] [Robert Stander] [Entered: 11/28/2018 06:26 PM] (711) |
| Nov 21, 2018 | 55 | REPLY BRIEF FILED for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [54]. Number of Pages: 31. Service: 11/21/2018 by email. Appendix is due 11/28/2018. [568126] [SJ] [Entered: 11/28/2018 10:24 AM] (37) |
| Nov 21, 2018 | 54 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: REPLY BRIEF. Service: 11/21/2018 by email. [567219] [18-1710] [Robert Stander] [Entered: 11/21/2018 03:25 PM] (37) |
| Oct 24, 2018 | 53 | 6 paper copies of the Intervenor Brief [51] received from Intervenor Iancu. [560266] [CJF] [Entered: 10/25/2018 09:03 AM] (0) |
| Oct 18, 2018 | 52 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [50] filed by Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and P.F. Laboratories, Inc. Reply brief is due 11/21/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [558476] [SJ] [Entered: 10/18/2018 12:51 PM] (0) |
| Oct 15, 2018 | 50 | MOTION of Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. to extend the time to 11/21/2018 to file the Appellants' Reply Brief. [Consent: unopposed]. Service: 10/15/2018 by email. [557296] [18-1710] [Robert Stander] [Entered: 10/15/2018 06:31 PM] (9) |
| Oct 10, 2018 | 51 | BRIEF FILED for Intervenor Iancu [49]. Number of Pages: 63. Service: 10/10/2018 by email. The paper copies of the brief should be received by the court on or before 10/25/2018. Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. reply brief is due 10/24/2018. [558440] [SJ] [Entered: 10/18/2018 12:04 PM] (81) |
| Oct 10, 2018 | 49 | TENDERED from Intervenor Iancu. Title: INTERVENOR BRIEF. Service: 10/10/2018 by email. [556145] [18-1710] [Mary Kelly] [Entered: 10/10/2018 04:07 PM] (81) |
| Sep 21, 2018 | 48 | **TEXT ONLY** ORDER granting motion to extend time to file brief [47] filed by Intervenor Iancu. Intervenor brief due 10/10/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [551761] [SJ] [Entered: 09/21/2018 03:04 PM] (0) |
| Sep 18, 2018 | 47 | MOTION of Intervenor Iancu to extend the time to 10/10/2018 to file the Intervenor's Brief. [Consent: unopposed]. Service: 09/18/2018 by email. [550717] [18-1710] [Mary Kelly] [Entered: 09/18/2018 01:19 PM] (4) |
| Aug 16, 2018 | 46 | **TEXT ONLY** ORDER granting motion to extend time to file brief [45] filed by Intervenor Iancu. Intervenor brief is due by 09/26/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [543464] [CMP] [Entered: 08/16/2018 03:26 PM] (0) |
| Aug 14, 2018 | 45 | MOTION of Intervenor Iancu to extend the time to 09/26/2018 to file the Intervenor's Brief. [Consent: unopposed]. Service: 08/14/2018 by email. [542762] [18-1710] [Mary Kelly] [Entered: 08/14/2018 01:50 PM] (5) |
| Aug 14, 2018 | 44 | Entry of appearance for Joseph Matal as of counsel for Intervenor Iancu. Service: 08/14/2018 by email. [542692] [18-1710] [Joseph Matal] [Entered: 08/14/2018 11:04 AM] (2) |
| Jul 26, 2018 | 43 | **TEXT ONLY** ORDER granting motion to extend time to file brief [42] filed by Intervenor Iancu. Intervenor brief due 08/27/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [538779] [SJ] [Entered: 07/26/2018 02:35 PM] (0) |
| Jul 23, 2018 | 42 | MOTION of Intervenor Iancu to extend the time to 08/27/2018 to file the Intervenor Brief. [Consent: unopposed]. Service: 07/23/2018 by email. [537818] [18-1710] [Mary Kelly] [Entered: 07/23/2018 02:41 PM] (4) |
| Jul 19, 2018 | 41 | Notice of Withdrawal of Director's Counsel - Nathan K. Kelley. Service: 07/19/2018 by clerk. [536940] [18-1167, 18-1171, 18-1285, 18-1286, 18-1289, 18-1595, 18-1609, 18-1633, 18-1651, 18-1659, 18-1710, 18-1711, 18-1712, 18-1714, 18-1730, 18-1772, 18-1773, 18-1828, 18-1847, 18-1876, 18-1883, 18-1901, 18-1998, 18-2017, 18-2048, 18-2049, 17-1765, 17-1825, 17-2292, 17-2294, 17-2392, 17-2465, 17-2543, 17-2047, 17-2620, 18-1071, 18-1172, 18-1173, 18-1557, 18-1593, 18-1795, 18-1895, 18-2000, 17-2122, 17-2124, 17-2239, 17-2241, 18-1013, 18-1047, 18-1048, 18-1070, 18-1242, 18-1353, 18-1849, 18-1958, 18-1992, 18-1994, 18-1995, 18-2043, 17-2364, 17-2579, 17-2580, 17-2593, 17-2594, 18-1067, 18-1069, 18-1077, 18-1163, 18-1166, 18-1253, 18-1311, 18-1368, 18-1385, 18-1426, 18-1944, 18-1968, 18-2031, 18-2032, 18-2069, 18-2106, 17-2503, 17-2624, 18-1000, 18-1060, 18-1065, 18-1066, 18-1416, 18-1461, 18-2090, 15-1242, 15-1944, 15-1945, 15-1946, 16-1794, 16-2222, 16-2470, 16-2548, 16-2640, 16-2669, 16-2736, 17-1159, 17-1265, 17-1266, 17-1268, 17-1362, 17-1425, 17-1486, 17-1578, 17-1582, 17-1629, 17-1666, 17-1722, 17-1827, 17-1849, 17-1870, 17-1953, 17-1954, 17-1955, 17-1957, 17-1962, 17-1963, 17-2037, 17-2038, 17-2069, 17-2208, 17-2232, 17-2244, 17-2255, 17-2263, 17-2361, 17-2424, 17-2426, 17-2447, 17-2524, 18-1085, 18-1088, 18-1122] [TAR] [Entered: 07/19/2018 10:11 AM] (2) |
| Jul 6, 2018 | 40 | 6 paper copies of the Opening Brief [39] received from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. [534123] [CJF] [Entered: 07/06/2018 03:53 PM] (0) |
| Jul 2, 2018 | 38 | TENDERED from Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P.. Title: OPENING BRIEF. Service: 07/02/2018 by email. [533254] [18-1710] [Robert Stander] [Entered: 07/02/2018 07:02 PM] (191) |
| Jul 2, 2018 | 39 | BRIEF FILED for Appellants P.F. Laboratories, Inc., Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. [38]. Number of Pages: 63. Service: 07/02/2018 by email. The paper copies of the brief should be received by the court on or before 07/11/2018. Intervenor brief is due 08/13/2018. [533502] [CFT] [Entered: 07/03/2018 02:50 PM] (191) |
| Jun 18, 2018 | 36 | Entry of appearance for Sarah E. Craven as of counsel for Intervenor Iancu. Service: 06/18/2018 by email. [530157] [18-1710] [Sarah Craven] [Entered: 06/18/2018 10:08 AM] (2) |
| Jun 18, 2018 | 37 | Docketing Statement for the Intervenor Iancu. Service: 06/18/2018 by email. [530168] [18-1710] [Mary Kelly] [Entered: 06/18/2018 10:24 AM] (3) |
| May 23, 2018 | 35 | Entry of appearance for Mary L. Kelly as of counsel for Intervenor Iancu. Service: 05/23/2018 by email. [523869] [18-1710] [Mary Kelly] [Entered: 05/23/2018 11:09 AM] (2) |
| May 23, 2018 | 34 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [523794] [CFT] [Entered: 05/23/2018 08:58 AM] (0) |
| May 21, 2018 | 33 | Official caption revised to reflect Notice of intervention from PTO. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [523078] [18-1710, 18-1711] [CFT] [Entered: 05/21/2018 08:50 AM] (0) |
| May 18, 2018 | 32 | Entry of appearance for Nathan K. Kelley as principal counsel for Intervenor - Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523028] [18-1710] [Nathan Kelley] [Entered: 05/18/2018 05:24 PM] (2) |
| May 18, 2018 | 31 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor - Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523025] [18-1710] [Thomas Krause] [Entered: 05/18/2018 05:20 PM] (2) |
| May 18, 2018 | 30 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 05/18/2018 by email. [523024] [18-1710] [Thomas Krause] [Entered: 05/18/2018 05:19 PM] (3) |
| May 1, 2018 | 29 | Certified list from the United States Patent and Trademark Office. Service: 05/01/2018 by email. Appellants' brief due 07/02/2018. [518219] [18-1710, 18-1711] [CFT] [Entered: 05/01/2018 04:12 PM] (106) |
| Apr 18, 2018 | 28 | ORDER filed. Amneal and Kashiv's motions to substitute or intervene [497874-2] [16] are denied. The revised official caption and short caption are revised based on Amneal's non-participation in these appeals and are reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days from the date of this order whether he wishes to intervene in these appeals. If the Director elects to participate as intervenor, his briefs shall be due no later than 40 days from the date of filing of Purdue's opening briefs. Purdue may file its reply briefs no later than 14 days from the date of filing of the Director's briefs. If the Director elects not to participate, Purdue shall file its appendixes no later than 20 days from the date of filing of its briefs. Service: 04/18/2018 by clerk. [514763] [18-1285, 18-1710] [LMS] [Entered: 04/18/2018 10:40 AM] (5) |
| Apr 9, 2018 | 27 | Docketing Statement for the Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 04/09/2018 by email. [511555] [18-1710] [Robert Stander] [Entered: 04/09/2018 09:10 AM] (4) |
| Apr 6, 2018 | 26 | Sealed or confidential document received [Kashiv Pharma, LLC] (corresponding to Doc No. [25]) for. Service: 04/06/2018 by email. [511495] [18-1710] [Thomas Meloro] [Entered: 04/06/2018 07:09 PM] (0) |
| Apr 6, 2018 | 25 | REPLY of Kashiv Pharma, LLC to response filed by Appellants, Doc. No [23]. Service: 04/06/2018 by email. [511494] [18-1710] [Thomas Meloro] [Entered: 04/06/2018 06:59 PM] (16) |
| Apr 6, 2018 | 24 | Notice to counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P., and The P.F. Laboratories, Inc.: The record of this case indicates that the Docketing Statement has not been filed. Docketing Statement due 04/16/2018. Service as of this date by the Clerk of Court. [511473] [CFT] [Entered: 04/06/2018 04:46 PM] (0) |
| Apr 4, 2018 | 23 | RESPONSE of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc. to the motion to substitute party [16] filed by Appellee Amneal Pharmaceuticals, LLC, motion to withdraw party [16] filed by Appellee Amneal Pharmaceuticals, LLC, motion for leave to intervene [16] filed by Appellee Amneal Pharmaceuticals, LLC. Service: 04/04/2018 by email. [510734] [18-1710] [Robert Stander] [Entered: 04/04/2018 10:37 PM] (30) |
| Apr 4, 2018 | 22 | RESPONSE of Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc. to the motion [16] filed by Appellee Amneal Pharmaceuticals, LLC, motion [16] filed by Appellee Amneal Pharmaceuticals, LLC, motion [16] filed by Appellee Amneal Pharmaceuticals, LLC. Service: 04/04/2018 by email. [510720] [18-1710] [Robert Stander] [Entered: 04/04/2018 05:53 PM] (30) |
| Mar 30, 2018 | 21 | Notice from Appellee Amneal Pharmaceuticals, LLC from Kashiv Pharma, LLC Notice of Non-Participation. Service: 03/30/2018 by email. [509576] [18-1710] [Thomas Meloro] [Entered: 03/30/2018 01:27 PM] (4) |
| Mar 29, 2018 | 20 | ORDER filed. Purdue is directed to respond to the motion no later than April 4, 2018. Any reply must be filed no later than April 6, 2018. Service: 03/29/2018 by clerk. [509352] [NL] [Entered: 03/29/2018 05:11 PM] (2) |
| Mar 28, 2018 | 17 | Sealed or confidential document received [Kashiv Pharma, LLC] (corresponding to Doc No. [16]), (corresponding to Doc No. [16]), (corresponding to Doc No. [16]) for Appellee Amneal Pharmaceuticals, LLC. Service: 03/28/2018 by email. [508871] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 07:19 PM] (0) |
| Mar 28, 2018 | 19 | Entry of appearance for Heather M. Schneider as of counsel for Kashiv Pharma, LLC. Service: 03/28/2018 by email. [508874] [18-1710] [Heather Schneider] [Entered: 03/28/2018 07:30 PM] (2) |
| Mar 28, 2018 | 18 | Entry of appearance for Heather M. Schneider as of counsel for Appellee Amneal Pharmaceuticals, LLC. Service: 03/28/2018 by email. [508873] [18-1710] [Heather Schneider] [Entered: 03/28/2018 07:26 PM] (2) |
| Mar 28, 2018 | 3 | ORDER consolidating appeals 18-1710 and 18-1711. Service as of this date by the Clerk of Court. [508683] [18-1710, 18-1711] [CAB] [Entered: 03/28/2018 01:34 PM] (2) |
| Mar 28, 2018 | 16 | MOTION of Kashiv Pharma, LLC Appellee Amneal Pharmaceuticals, LLC to substitute party. Any response is due within 10 days of service., to withdraw party, Amneal Pharmaceuticals LLC, as a party to this appeal. Any response is due within 10 days of service., for leave to intervene. Any response is due within 10 days of service. [Consent: opposed]. Service: 03/28/2018 by email. [508870] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 07:01 PM] (98) |
| Mar 28, 2018 | 15 | Docketing Statement for the Appellee Amneal Pharmaceuticals, LLC. Service: 03/28/2018 by email. [508867] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 06:42 PM] (4) |
| Mar 28, 2018 | 14 | Certificate of Interest for the Appellee Amneal Pharmaceuticals, LLC. Service: 03/28/2018 by email. [508865] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 06:36 PM] (3) |
| Mar 28, 2018 | 13 | Entry of appearance for Thomas J. Meloro as principal counsel for Kashiv Pharma, LLC. Service: 03/28/2018 by email. [508864] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 06:31 PM] (2) |
| Mar 28, 2018 | 12 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellee Amneal Pharmaceuticals, LLC. Service: 03/28/2018 by email. [508863] [18-1710] [Thomas Meloro] [Entered: 03/28/2018 06:25 PM] (2) |
| Mar 28, 2018 | 11 | Certificate of Interest for the Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508759] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 03:05 PM] (3) |
| Mar 28, 2018 | 10 | Entry of appearance for John J. Normile as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508758] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 03:04 PM] (2) |
| Mar 28, 2018 | 9 | Entry of appearance for Gasper J. LaRosa as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508755] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 03:02 PM] (2) |
| Mar 28, 2018 | 8 | Entry of appearance for Robert Stander as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508752] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 03:01 PM] (2) |
| Mar 28, 2018 | 7 | Entry of appearance for Gregory A. Castanias as principal counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508750] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 03:00 PM] (2) |
| Mar 28, 2018 | 6 | Entry of appearance for Jennifer L. Swize as of counsel for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc.. Service: 03/28/2018 by email. [508746] [18-1710] [Jennifer Swize] [Entered: 03/28/2018 02:58 PM] (2) |
| Mar 28, 2018 | 5 | Note to file: 18-1710 (COMPANION started 03/28/2018) with 18-1285. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [508688] [18-1285, 18-1710] [CAB] [Entered: 03/28/2018 01:42 PM] (0) |
| Mar 28, 2018 | 4 | Note to file: The following cases are consolidated: 18-1710 Lead with 18-1711 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [508684] [18-1710, 18-1711] [CAB] [Entered: 03/28/2018 01:36 PM] (0) |
| Mar 22, 2018 | 1 | Appeal docketed. Received: 03/20/2018. [507160] Entry of Appearance due 04/05/2018. Certificate of Interest is due on 04/05/2018. Docketing Statement due 04/05/2018. Certified List due on 05/01/2018. [CFT] [Entered: 03/22/2018 01:23 PM] (7) |
| Mar 22, 2018 | 2 | Sealed or confidential document received [Final Written Decision] (corresponding to Doc No. [1]) for Appellants Purdue Pharma L.P., Purdue Pharmaceuticals L.P. and The P.F. Laboratories, Inc. Service: 03/22/2018 by clerk. [507162] [CFT] [Entered: 03/22/2018 01:26 PM] (0) |
